The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.
Official Title: Open Label, Phase II Study of Capecitabine (Xeloda®) as Fluoropyrimidine of Choice in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer Suitable for Treatment With a Fluoropyrimidine-Based Regimen
Study ID: NCT00454636
Brief Summary: This study will assess the safety and efficacy of Xeloda, given in combination with standard chemotherapy regimens, for the first-line treatment of advanced and/or metastatic gastric cancer. All patients will receive Xeloda in combination with one of 4 standard chemotherapy regimens; the dose of Xeloda will be from 625mg/m2 - 1000mg/m2 bid orally, depending on the chemotherapy regimen used. The anticipated time on study treatment is until disease progression, and the target sample size is 100-500 individuals.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
, Alcoy, Alicante, Spain
, Gijon, Asturias, Spain
, Cádiz, Cadiz, Spain
, Jerez de La Frontera, Cadiz, Spain
, Puerto Real, Cadiz, Spain
, San Sebastian, Guipuzcoa, Spain
, Barbastro, Huesca, Spain
, Palma De Mallorca, Islas Baleares, Spain
, Palma de Mallorca, Islas Baleares, Spain
, Ferrol, La Coruña, Spain
, Santiago de Compostela, La Coruña, Spain
, Logroño, La Rioja, Spain
, Alcorcon, Madrid, Spain
, Pamplona, Navarra, Spain
, Vigo, Pontevedra, Spain
, La Laguna, Tenerife, Spain
, Bilbao, Vizcaya, Spain
, Avila, , Spain
, Barcelona, , Spain
, Burgos, , Spain
, Castellon, , Spain
, Cordoba, , Spain
, Girona, , Spain
, Granada, , Spain
, Granada, , Spain
, Guadalajara, , Spain
, Huesca, , Spain
, Jaen, , Spain
, La Coruña, , Spain
, La Coruña, , Spain
, Leon, , Spain
, Lerida, , Spain
, Lugo, , Spain
, Madrid, , Spain
, Madrid, , Spain
, Madrid, , Spain
, Madrid, , Spain
, Madrid, , Spain
, Madrid, , Spain
, Madrid, , Spain
, Murcia, , Spain
, Navarra, , Spain
, Orense, , Spain
, Palencia, , Spain
, Pontevedra, , Spain
, Salamanca, , Spain
, Sevilla, , Spain
, Toledo, , Spain
, Valencia, , Spain
, Valencia, , Spain
, Zaragoza, , Spain
Name: Clinical Trials
Affiliation: Hoffmann-La Roche
Role: STUDY_DIRECTOR